Упрощенная HTML-версия
190.
Inflammatory cytokine production enhancement in the presence of
lipopolysaccharide after hepatic resection in cirrhotic patients / T. Sato, Y.
Asanuma, J. Tanaka, K. Koyama // Ther. Apher. - 1997. - Vol.1,№1. - Р. 75-78.
191.
Influence of interleukin-10 gene promoter polymorphisms on disease
progression in patients chronically infected with hepatitis B virus / S. Miyazoe, K.
Hamasaki, K. Nakata et al. // Am. J. Gastroenterol. - 2002. - Vol.97,№8. - Р.
2086-2092.
192.
Interferon-alpha induces interleukin-18 binding protein in chronic hepatitis C
patients / A. Kaser, D. Novick, M. Rubinstein et al. // Clin. Exp. Immunol. - 2002.
- Vol.129,№2. - Р. 332-338.
193.
Interleukin 10 haplotype associated with increased risk of hepatocellular
carcinoma / H.D. Shin, B.L. Park, L.H. Kim et al. // Hum. Mol. Genet. - 2003. -
Vol.12,№8. -Р. 901-906.
194.
Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and
liver fibrosis induced by carbon tetrachloride in mice / H. Louis, J.L.Van
Laethem, W. Wu et al. // Hepatology. - 1998. - Vol.28,№6. - Р. 1607-1615.
195.
Interleukin-10 expression and function in experimental murine liver
inflammation and fibrosis / K. Thompson, J. Maltby, J. Fallowfield et al. //
Hepatology. - 1998. -Vol.28,№6. - Р. 1597-1606.
196.
Interleukin-10 promoter polymorphism predicts initial response of chronic
hepatitis C to interferon alfa / C.J. Edwards-Smith, J.R. Jonsson, D.M. Purdie et
al. // Hepatology. - 1999. - Vol.30,№2. - Р. 526-530.
197.
Interleukin-11 reduces T-cell-dependent experimental liver injury in mice / M.
Bozza, J.L. Bliss, R. Maylor et al. // Hepatology.- 1999. - Vol.30,№6. - Р. 1441-
1447.